Cardioprotection for Acute MI in Light of the CONDI2/ERIC-PPCI Trial: New Targets Needed
Protection against ischaemia–reperfusion injury after revascularisation in acute myocardial infarction remains an enigma. Many targets have been identified, but after the failure of the recent Effect of Remote Ischaemic Conditioning on Clinical Outcomes in ST-elevation Myocardial Infarction Patients...
Guardado en:
Autores principales: | Joel P Giblett, Heerajnarain Bulluck |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3741efb2e11b441eba1d4af3de1e62cf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ISCHEMIA Trial and the Significance of MI
por: Eduardo A Arias, et al.
Publicado: (2020) -
What an Interventionalist Needs to Know About MI with Non-obstructive Coronary Arteries
por: Robert Sykes, et al.
Publicado: (2021) -
Patent Foramen Ovale Closure in 2019
por: Joel P Giblett, et al.
Publicado: (2019) -
Patent Foramen Ovale Closure: State of the Art
por: Joel P Giblett, et al.
Publicado: (2020) -
Clinical profile of patients with qRBBB MI at tertiary care centre
por: Achal Sharma, et al.
Publicado: (2021)